This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gläsker, S. Articles by Vortmeyer, A. O. Search for Related Content PubMed PubMed Citation Articles by Gläsker, S. Articles by Vortmeyer, A. O.

Hemangioblastomas Share Protein Expression with Embryonal Hemangioblast Progenitor Cell

¹ Surgical Neurology Branch, National Institutes of Neurological Disorders and Stroke, NIH, Bethesda, Maryland and ² Neurochirurgische Universitätsklinik, Albert-Ludwigs Universität, Freiburg, Germany

Requests for reprints: Alexander Vortmeyer, Surgical Neurology Branch, National Institute of Neurological Diseases and Stroke, Building 10, Room 5D37, 10 Center Drive, Bethesda, MD 20892. Phone: 301-496-5728; Fax: 301-402-0380; E-mail: vortmeyera{at}mail.nih.gov.

Hemangioblastomas are central nervous system (CNS) tumors of unknown histogenesis, which can occur sporadically or in von Hippel-Lindau disease. Hemangioblastomas are composed of neoplastic "stromal" cells of unknown origin, accompanied by intensive reactive angiogenesis. Failure to specify the cytologic origin of the stromal cell has precluded the development of nonsurgical therapies and limits understanding of its basic biology. We report that the stromal cells express proteins (Scl, brachyury, Csf-1R, Gata-1, Flk-1, and Tie-2) that characterize embryonic progenitor cells with hemangioblastic differentiation potential and conclude that embryonic progenitors with hemangioblast potential represent a possible cytologic equivalent of the stromal cell. We also identified a new autocrine/paracrine stimulatory loop between the receptor Tie-2 and the hypoxia-inducible factor target Ang-1, which, combined with previous observations, suggests that a variety of autocrine loops may be initiated in hemangioblastomas, depending on the differentiation status of the tumor cells and the extent of HIF downstream activation. Finally, the consistent identification of Scl in the stromal cells may help explain the unique and characteristic topographical distribution of hemangioblastomas within the CNS. (Cancer Res 2006; 66(8):4167-72)

This article has been cited by other articles:

				M.-Y. Son, J. Kim, H.-W. Han, S.-M. Woo, Y. S. Cho, Y.-K. Kang, and Y.-M. Han Expression profiles of protein tyrosine kinase genes in human embryonic stem cells Reproduction, October 1, 2008; 136(4): 423 - 432. [Abstract] [Full Text] [PDF]

				J. A. Butman, W. M. Linehan, and R. R. Lonser Neurologic Manifestations of von Hippel-Lindau Disease JAMA, September 17, 2008; 300(11): 1334 - 1342. [Abstract] [Full Text] [PDF]

				J. Sausville, A. A. Molinolo, X. Cheng, J. Frampton, N. Takebe, J. S. Gutkind, and R. A. Feldman RCAS/SCL-TVA Animal Model Allows Targeted Delivery of Polyoma Middle T Oncogene to Vascular Endothelial Progenitors In vivo and Results in Hemangioma Development Clin. Cancer Res., June 15, 2008; 14(12): 3948 - 3955. [Abstract] [Full Text] [PDF]